The changing base line of complex ventricular arrhythmias. A new consideration in assessing long-term antiarrhythmic drug therapy

The New England Journal of Medicine
C M PrattR Roberts


Initial base-line electrocardiograms are used to assess the efficacy of treatment for ventricular arrhythmias. This approach assumes that in the absence of treatment the frequency of arrhythmia would remain constant. To test the validity of this assumption, we studied 26 clinically stable patients with symptomatic but not life-threatening ventricular arrhythmias, during two periods of placebo treatment separated by a mean of 17 months. As compared with the initial placebo period, there were significant reductions in ventricular premature depolarizations (50 per cent), pairs (65 per cent), and ventricular tachycardia (83 per cent) during the second period of placebo administration (P less than or equal to 0.05 for all comparisons). Over one third of the patients gave the appearance of receiving successful therapy during the second placebo period, even when the reported spontaneous variability of ventricular arrhythmia was taken into consideration. If unrecognized, these long-term spontaneous changes in the frequency of arrhythmia could result in continuation of unnecessary and potentially toxic therapy and lead to incorrect conclusions regarding the efficacy of antiarrhythmic drugs in clinical trials. We therefore recommend that...Continue Reading


Oct 6, 1977·The New England Journal of Medicine·W RubermanS Shapiro
May 22, 1978·The American Journal of Cardiology·D C HarrisonR A Winkle
May 1, 1978·Circulation·R A WinkleD C Harrison
Feb 12, 1976·The New England Journal of Medicine·D C HarrisonR A Winkle
Jan 24, 1985·The New England Journal of Medicine·H L KennedyR J Goldberg
Mar 1, 1980·Archives of Internal Medicine·K S LoB Pitt
Sep 1, 1982·The American Journal of Cardiology·T B GraboysR DeSilva
Dec 1, 1982·The American Journal of Cardiology·B OlshanskyS Hunt
Sep 22, 1983·The American Journal of Cardiology·D C Harrison
Sep 1, 1984·Journal of the American College of Cardiology·M J ChowA J Atkinson
Feb 27, 1984·The American Journal of Cardiology·M HodgesG Granrud
Apr 1, 1983·The American Journal of Cardiology·R A WinkleD C Harrison
Dec 1, 1980·Australian and New Zealand Journal of Medicine·B L Chia
Dec 1, 1980·Circulation·M SamiR F DeBusk

❮ Previous
Next ❯


Aug 1, 1987·Journal of the American College of Cardiology·B Surawicz
May 17, 2000·Journal of Clinical Epidemiology·K R EvensonR J Simpson
May 1, 1987·Journal of Clinical Pharmacology·S M MohiuddinL A Stengel
Feb 20, 1990·The American Journal of Cardiology·S A Mahler, R M Borland
May 1, 1987·The American Journal of Cardiology·P R KoweyL A Yeager
Aug 1, 1994·Circulation·J K GilmanG V Naccarelli
Feb 8, 1989·The Journal of Pharmacy Technology : JPT : Official Publication of the Association of Pharmacy Technicians·F PucinoC L Beck
Sep 6, 2012·Scandinavian Journal of Medicine & Science in Sports·L CaselliA Michelucci
May 1, 1993·The Annals of Pharmacotherapy·S M MohiuddinM H Sketch
Jan 1, 1989·Pharmacotherapy·P L McCollamJ L Bauman

❮ Previous
Next ❯

Related Concepts

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.